FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of July, 2004
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Directorate Change
Appointment and Resignation of Directors
Celltech Group plc announces that the following Directors have retired from the Board:
Dr P J
Fellner
Sir Tom
Blundell
Prof C R W
Edwards
Mr M G
Newmarch
Dr P R Read
Mr P H G
Cadbury
Mr P G
Rogerson
Mrs I Saunders
Celltech Group plc announces that the following Directors have been appointed to the Board:
Mr Roch
Doliveux
Mr Marc
Wiers
Mr
Jean-Pierre Pradier
Mr André Khairallah
J A D Slater
Company Secretary
7 July 2004
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 7 July, 2004